Stoke Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell STOK and other ETFs, options, and stocks.

About STOK

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.

CEO

Ian Frederick Smith

CEOIan Frederick Smith

Employees

128

Employees128

Headquarters

Bedford, Massachusetts

HeadquartersBedford, Massachusetts

Founded

2014

Founded2014

Employees

128

Employees128

STOK Key Statistics

Market cap

635.51M

Market cap635.51M

Price-Earnings ratio

14.43

Price-Earnings ratio14.43

Dividend yield

—

Dividend yield—

Average volume

646.26K

Average volume646.26K

High today

$12.00

High today$12.00

Low today

$11.19

Low today$11.19

Open price

$11.25

Open price$11.25

Volume

464.30K

Volume464.30K

52 Week high

$16.15

52 Week high$16.15

52 Week low

$5.35

52 Week low$5.35

Analyst ratings

100%

of 9 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own STOK. This list is generated using Robinhood data, and it’s not a recommendation.

Stoke Therapeutics

Why Robinhood?

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver. Show more

STOK Key Statistics

Analyst ratings

100%

People also own

Stoke Therapeutics, Inc. is a biotechnology company, which engages in the research and development of treatments for genetic diseases. It offers a wide range of relevant tissues including the central nervous system, eye, kidney, and liver.